FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely, to therapy, cardiology, in particular, refers to planning for the prevention and treatment of patients at risk or already suffering from diseases such as cardiovascular disease, and can be used to determine the coronary status of a person, as well as to prevent and monitor the risk of developing cardiovascular diseases. Method is performed by determining a coronary code represented in the form of a four-digit numerical record, determined by obtaining data from a visual assessment of the patient's coronary arteries using computed tomography, coronary angiography data, summary data on cardiovascular risk according to the SCORE scale and data on cardiovascular risk factors for the additional coronary risk scale EFIR, and the EFIR scale contains: 1 - low risk group, which includes patients who score less than 5 points, and which has a value of 0; 2 - high-risk group, which includes patients who have scored 5 or more points, and which has a value of 1, and the score is calculated on the basis of the evaluation of the indices: fasting plasma glucose - 5.6-6.9 mmol/l - 1 point; increase in C-reactive protein (>5 mg/l) - 1 point; body mass index >30 kg/m2 - 0.5 points; abdominal obesity (waist >100 cm) - 1 point; high-density lipoproteins <1.0 for men and <1.2 for women - 1 point; subclinical affection of carotid arteries (stenosis >50%) - 0.5 points; hereditary history of early cardiovascular diseases in relatives of 1 line at the age of <45 in men, <55 years in women - 1 point; hypodynamia - 0.5 points; presence of hypertrophy of the left ventricle - 0.5 points; professions associated with increased psychoemotional overloads - 1 point; marital status (single men) - 0.5 points; depression, estimated on the Beck scale - 0.5 points. Also, data on the presence of percutaneous coronary intervention and/or coronary artery bypass, and subsequent analysis of the data obtained by mathematical methods using software are used. Obtain the final coronary code of the person presented in the form of a four-digit numerical record. Determine the belonging of the human coronary code to one of the coronary groups by conducting a comparative analysis of four-digit numerical records of coronary codes. Establish a coronary status of a person on the basis of a person's belonging to a particular coronary group. Application includes the design of the visit, the primary determination of the coronary status and the conduct of therapeutic and prophylactic measures taking into account the revealed coronary status with subsequent determination of coronary status changes at specified intervals and the appointment of therapeutic and prophylactic measures corresponding to the newly revealed coronary status of a person. Data on the detected coronary status and the prescribed treatment and prophylactic measures are recorded on an electronic medium that is a means of nosological identification of a person and the key of access to the global information network, preferably the Internet, through which the doctor-patient interacts automatically with the latest results of the study, treatment and diagnostic activities, and the prevention and/or treatment program.
EFFECT: group of inventions allows the use of a universal automated system for monitoring and preventing the development of cardiovascular diseases, based on a method for identifying the risk of developing cardiovascular diseases.
4 cl, 2 dwg, 11 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING INDIVIDUAL PROFILE OF TOTAL CARDIOVASCULAR RISK FACTORS IN PATIENT OF WORKING AGE | 2021 |
|
RU2757752C1 |
METHOD OF EVALUATION OF CARDIOVASCULAR RISK IN PATIENTS WITH COPD ON THE SMOKING BACKGROUND | 2017 |
|
RU2654290C1 |
METHOD FOR PREDICTING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LOW OR MODERATE CARDIOVASCULAR RISK BY ASSESSING THEIR PSYCHOLOGICAL STATUS | 2020 |
|
RU2750716C1 |
METHOD FOR ASSESSING RISK OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS WITH CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS | 2014 |
|
RU2574896C2 |
METHOD FOR ESTIMATING THE RISK OF BLEEDING OF THE UPPER GASTROINTESTINAL TRACT IN PATIENTS WITH STABLE ISCHAEMIC HEART DISEASE | 2021 |
|
RU2778202C1 |
METHOD OF PREVENTING ACUTE CORONARY SYNDROME IN MEN WITH ARTERIAL HYPERTENSION WITH MODERATE RISK OF DEVELOPMENT OF ACUTE CARDIOVASCULAR COMPLICATIONS | 2012 |
|
RU2483671C1 |
A METHOD FOR PREDICTING THE RISK OF ATHEROSCLEROSIS OF THE CAROTID ARTERIES IN PEOPLE 30-49 YEARS OF SLAVIC AND KOREAN ETHNICITY | 2022 |
|
RU2787738C1 |
METHOD FOR ASSESSING RISK OF CARDIOVASCULAR COMPLICATIONS IN POSTMENOPAUSAL FEMALES | 2013 |
|
RU2527356C1 |
METHOD FOR DETERMINING THE OPTIMAL STRATEGY OF REVASCULARIZATION IN PATIENTS WITH SIMULTANEOUS ATHEROSCLEROTIC LESIONS OF THE BRACHIOCEPHALIC AND CORONARY ARTERIES | 2017 |
|
RU2681581C1 |
METHOD OF PREDICTION RISK OF ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS FOR 6 YEARS AFTER SCHEDULED ENDOVASCULAR MYOCARDIUM REVASCULARIZATION | 2017 |
|
RU2642930C1 |
Authors
Dates
2018-08-15—Published
2016-05-05—Filed